These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 32468456)

  • 1. Three-Dimensional Models for Studying Neurodegenerative and Neurodevelopmental Diseases.
    Tsaridou S; Skamnelou M; Iliadou M; Lokka G; Parlapani E; Mougkogianni M; Danalatos RI; Kanellou A; Chlorogiannis DD; Kyrousi C; Taraviras S
    Adv Exp Med Biol; 2020; 1195():35-41. PubMed ID: 32468456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 3D brain Organoids derived from pluripotent stem cells: promising experimental models for brain development and neurodegenerative disorders.
    Lee CT; Bendriem RM; Wu WW; Shen RF
    J Biomed Sci; 2017 Aug; 24(1):59. PubMed ID: 28822354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synaptic dysfunction in neurodegenerative and neurodevelopmental diseases: an overview of induced pluripotent stem-cell-based disease models.
    Taoufik E; Kouroupi G; Zygogianni O; Matsas R
    Open Biol; 2018 Sep; 8(9):. PubMed ID: 30185603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain organoids: A new tool for modelling of neurodevelopmental disorders.
    Aili Y; Maimaitiming N; Wang Z; Wang Y
    J Cell Mol Med; 2024 Sep; 28(17):e18560. PubMed ID: 39258535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation of iPSC-derived Human Brain Organoids to Model Early Neurodevelopmental Disorders.
    Gabriel E; Gopalakrishnan J
    J Vis Exp; 2017 Apr; (122):. PubMed ID: 28448044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Astrocytes in a dish: Using pluripotent stem cells to model neurodegenerative and neurodevelopmental disorders.
    Crompton LA; Cordero-Llana O; Caldwell MA
    Brain Pathol; 2017 Jul; 27(4):530-544. PubMed ID: 28585380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Central nervous system organoids for modeling neurodegenerative diseases.
    Hou PS; Kuo HC
    IUBMB Life; 2022 Aug; 74(8):812-825. PubMed ID: 35102668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro modeling for inherited neurological diseases using induced pluripotent stem cells: from 2D to organoid.
    Nam KH; Yi SA; Jang HJ; Han JW; Lee J
    Arch Pharm Res; 2020 Sep; 43(9):877-889. PubMed ID: 32761309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro models for ASD-patient-derived iPSCs and cerebral organoids.
    Hohmann SS; Ilieva M; Michel TM
    Prog Mol Biol Transl Sci; 2020; 173():355-375. PubMed ID: 32711817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances and Applications of Brain Organoids.
    Li Y; Zeng PM; Wu J; Luo ZG
    Neurosci Bull; 2023 Nov; 39(11):1703-1716. PubMed ID: 37222855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The contribution of cerebral organoids to the understanding and treatment of rare genetic diseases with neurodevelopmental disorders].
    El It F; Faivre L; Thauvin-Robinet C; Vitobello A; Duplomb L
    Med Sci (Paris); 2024; 40(8-9):643-652. PubMed ID: 39303116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. From Neuronal Differentiation of iPSCs to 3D Neuro-Organoids: Modelling and Therapy of Neurodegenerative Diseases.
    Bordoni M; Rey F; Fantini V; Pansarasa O; Di Giulio AM; Carelli S; Cereda C
    Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30544711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optogenetics in the Era of Cerebral Organoids.
    Shiri Z; Simorgh S; Naderi S; Baharvand H
    Trends Biotechnol; 2019 Dec; 37(12):1282-1294. PubMed ID: 31227305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human Models Are Needed for Studying Human Neurodevelopmental Disorders.
    Zhao X; Bhattacharyya A
    Am J Hum Genet; 2018 Dec; 103(6):829-857. PubMed ID: 30526865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Great Expectations: Induced pluripotent stem cell technologies in neurodevelopmental impairments.
    Zhang X; Li Z; Liu Y; Gai Z
    Int J Med Sci; 2021; 18(2):459-473. PubMed ID: 33390815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Emergence of Stem Cell-Based Brain Organoids: Trends and Challenges.
    Gopalakrishnan J
    Bioessays; 2019 Aug; 41(8):e1900011. PubMed ID: 31274205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opportunities and challenges for the use of induced pluripotent stem cells in modelling neurodegenerative disease.
    Wu YY; Chiu FL; Yeh CS; Kuo HC
    Open Biol; 2019 Jan; 9(1):180177. PubMed ID: 30958120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studying Human Neurological Disorders Using Induced Pluripotent Stem Cells: From 2D Monolayer to 3D Organoid and Blood Brain Barrier Models.
    Logan S; Arzua T; Canfield SG; Seminary ER; Sison SL; Ebert AD; Bai X
    Compr Physiol; 2019 Mar; 9(2):565-611. PubMed ID: 30873582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brain-on-a-Chip: A Human 3D Model for Clinical Application.
    Muzzi L; Martinoia S; Frega M
    Stud Health Technol Inform; 2019; 261():274-279. PubMed ID: 31156129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unlocking Neural Function with 3D In Vitro Models: A Technical Review of Self-Assembled, Guided, and Bioprinted Brain Organoids and Their Applications in the Study of Neurodevelopmental and Neurodegenerative Disorders.
    D'Antoni C; Mautone L; Sanchini C; Tondo L; Grassmann G; Cidonio G; Bezzi P; Cordella F; Di Angelantonio S
    Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.